View Author
scopus: 7006567568

Morein, B.

(Bror Morein)


virus iscom vaccine monkey rabie antibody protein challenge preparation group gp 70 protection immunization titre figure serum elisa animal felv iscoms response vaccination group b vaccinated rhesu antigen analysis infection rhesus pbmc 3 rd edn siv-mdp siv-iscom table morein immunity street rabies virus sivmac postexposure gpl 20 envelope experiment dilution disease method dogs vaccinated siv-specific development eds kaplan cell-associated siv laboratory techniques health subunit wb analysis siv vaccine preparations strain c 8166 cells street koprowski vaccine preparations stock study rabies virus siv-iscom-immunized 6 weeks gpl 20-inhibition elisa sds-polyacrylamide gel electrophoresis gpl 20-enriched iscoms diploid cell vaccine siv-specific immunity siv-mdp-immunized monkeys siv-iscom-immunized monkeys t n buffer aids res world siv-immunized monkeys cell-associated presence iscom preparation immunodeficiency g-protein laboratory




5 Most Recent Publications

Protection of rhesus macaques from SIV infection by immunization with different experimental SIV vaccines. (Article)
Vries, P. de Heeney, J.L. Morein, B. Norley, S. Osterhaus, A.D.M.E. Boes, J. Dings, M.E.M. Hulskotte, E.G.J. Dubbes, R. Koornstra, W. Haaft, P. ten Akerblom, L. Eriksson, S.
1994-11-11
An immune stimulating complex (iscom) subunit rabies vaccine protects dogs and mice against street rabies challenge. (Article)
Fekadu, M. Schaddock, J.H. Ekström, J. Osterhaus, A.D.M.E. Sanderlin, D.W. Sundquist, B. Morein, B.
1992-01-31
Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccines. (Article)
Heeney, J.L. Vries, P. de Dubbes, R. Koornstra, W. Niphuis, H. Haaft, P. ten Boes, J. Dings, M.E.M. Morein, B. Osterhaus, A.D.M.E.
1992-01-01
Formation and characterization of FeLV iscoms. (Article)
Akerblom, L. Strömstedt, K. Höglund, S. Osterhaus, A.D.M.E. Morein, B.
1989-01-01
Comparison of serological responses in cats vaccinated with two different FeVL vaccine preparations. (Article)
Osterhaus, A.D.M.E. Weijer, K. UytdeHaag, F. Knell, P. Jarrett, O. Morein, B.
1987-01-01